A Phase II Trial of Erlotinib in Combination With Gemcitabine and Cisplatin for Unresectable Pancreatic Cancer

European Journal of Cancer(2011)

Cited 1|Views24
No score
Key words
unresectable pancreatic cancer,pancreatic cancer,erlotinib,cisplatin,gemcitabine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined